信息披露违法违规

Search documents
英飞拓股民索赔案再获法院立案,实达集团索赔案持续推进
Xin Lang Cai Jing· 2025-09-17 01:48
Group 1 - The investor compensation case against Infitop (002528) has been filed again in Shenzhen Intermediate People's Court, with ongoing efforts to accept more claims from investors [1] - The China Securities Regulatory Commission (CSRC) issued a notice of investigation to Infitop on January 24, 2025, due to suspected violations of information disclosure laws [1] - Investors who purchased Infitop shares between April 30, 2020, and April 30, 2024, and sold or continued to hold the shares after April 30, 2024, are eligible to initiate claims [1] Group 2 - The compensation case for Shida Group (600734) is also being pursued, with a filing submitted to Fuzhou Intermediate People's Court and ongoing acceptance of claims from other investors [1] - The CSRC issued an administrative penalty decision on March 14, 2024, confirming that Shida Group failed to disclose important contract signing matters and had false records in its temporary reports [2] - In 2020, Shida Group sold inventory to three companies in Hong Kong, failing to recover a total of $0.18 billion, which accounted for 78.26% of the sales revenue [2] Group 3 - Investors who bought Shida Group shares between September 18, 2021, and May 16, 2023, and sold or continued to hold the shares after May 16, 2023, can also initiate claims [3] - The law firm has a history of successfully representing investors in securities fraud cases, having handled nearly 200 cases with successful outcomes [3]
ST应急收行政处罚决定书,多项违规致百万罚款
Xin Lang Cai Jing· 2025-09-16 12:45
2024年10月18日,ST应急因涉嫌信息披露违法违规被中国证监会立案。2025年9月16日,公司及相关当 事人收到湖北监管局《行政处罚决定书》。经查明,公司2022年年报存在收入确认和坏账计提不准确的 会计差错,综合导致当年营业收入多计3137.24万元、利润总额多计714.03万元。公司被给予警告,并处 400万元罚款;时任董事长唐勇等3人也被警告并罚款。公司表示不触及重大违法强制退市情形,已完成 整改,将在处罚决定作出12个月后申请撤销其他风险警示,目前经营正常。 ...
天圣制药信披违规遭警告、罚款 股票被叠加“其他风险警示”
Xin Jing Bao· 2025-09-16 11:21
Core Viewpoint - Tian Sheng Pharmaceutical Group Co., Ltd. (referred to as "Tian Sheng Pharmaceutical") has been penalized by the China Securities Regulatory Commission (CSRC) for inflating profits and failing to disclose related party transactions in its annual reports, resulting in a total fine of 4.99 million yuan for the company and 22 individuals, including the controlling shareholder Liu Qun [2][5]. Group 1: Financial Misconduct - Tian Sheng Pharmaceutical inflated its total profit by 175 million yuan and 47.9 million yuan in the 2017 and 2018 annual reports, respectively, through the use of off-the-books funds [3]. - The company also inflated its procurement costs for traditional Chinese medicine, resulting in a profit reduction of 82.58 million yuan and 19.09 million yuan for the same years, leading to a net profit inflation of 92.20 million yuan and 28.82 million yuan, which accounted for 30.21% and 20.61% of the reported profits for those years [3][4]. Group 2: Related Party Transactions - Tian Sheng Pharmaceutical failed to disclose related party transactions amounting to 481 million yuan and 48.63 million yuan for 2017 and 2018, respectively, which represented 15.08% and 1.49% of the net assets at the end of those periods [4]. - The company did not include its subsidiary, Chongqing Taihong Construction Engineering Co., Ltd., in its consolidated financial statements, nor did it disclose transactions with companies controlled by Liu Qun [4]. Group 3: Legal and Financial Consequences - The CSRC has ordered Tian Sheng Pharmaceutical to correct its disclosures and has imposed fines, including 600,000 yuan for the company and 900,000 yuan for Liu Qun [5]. - Tian Sheng Pharmaceutical has reported continuous losses over the past six and a half years, with a cumulative loss of 1.09 billion yuan, and its revenue has been declining since 2018 [6][7]. - The company’s stock has been under risk warnings since June 5, 2019, due to the controlling shareholder's involvement in fund misappropriation, and additional warnings will be implemented starting September 15, 2025, due to false financial disclosures [8].
司尔特融资净买入355.6万元,正被调查受损投资者可报名挽损
Sou Hu Cai Jing· 2025-09-16 08:31
Core Viewpoint - The company, Si Er Te, is currently under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may lead to potential compensation claims from affected investors [3]. Group 1: Financing Activities - On September 15, Si Er Te had a financing buy-in of 7.175 million yuan, with a financing repayment of 3.619 million yuan, resulting in a net financing buy of 3.556 million yuan. This marks a cumulative net buy of 22.022 million yuan over the past five days [2]. Group 2: Regulatory Actions - On September 1, Si Er Te received a notice from the CSRC regarding an investigation into the company for suspected information disclosure violations, which could lead to legal consequences under relevant laws [3]. - Affected investors who purchased shares between April 20, 2022, and April 25, 2025, and held them until the latter date may be eligible for compensation claims [3]. Group 3: Accounting Policy Changes - On April 30, Si Er Te announced a change in accounting policies in accordance with the Ministry of Finance's new guidelines, which does not require board or shareholder approval [4]. - The company stated that the accounting policy change will not affect previously disclosed financial statements and will not have a significant impact on its financial status, operating results, or cash flows [5].
东方通被预处罚,股民索赔可期
Xin Lang Cai Jing· 2025-09-15 07:35
登录新浪财经APP 搜索【信披】查看更多考评等级受损股民可至新浪股民维权平台登记该公司维权: http://wq.finance.sina.com.cn/关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问 新浪财经客户端、新浪财经首页都能找到我们! 2025年9月13日,北京东方通科技股份有限公司(简称:东方通、*ST东通(维权),代码:300379) 发布《关于收到行政处罚事先告知书的公告》。 经中国证监会查明,东方通涉嫌违法的主要事实如下: 一、东方通2019年、2020年、2021年、2022年年度报告信息披露存在虚假记载。 2018年12月,东方通 收购北京泰策科技有限公司(以下简称泰策科技)100%股权,泰策科技成为东方通全资子公司。2019年至 2022年期间,东方通通过泰策科技虚构业务、提前确认收入等方式虚增收入、利润,导致东方通披露的 2019年至2022年年度报告存在虚假记载。东方通2019年至2022年分别虚增收入 6,145.10万元、8,485.06 万元、12,550.58万元、16,052.95万元,分别占公司当期披露营业收入的12.29%、13.25%、14.54% ...
际华集团主力净流出1134.28万元,此前被立案律师征集受损股民报名挽损
Sou Hu Cai Jing· 2025-09-15 07:03
Group 1 - On September 12, the trading volume of Jihua Group reached 396 million yuan, with a net outflow of 11.34 million yuan from major investors [2] - On August 8, Jihua Group received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws [2] - Investors who suffered losses due to the company's failure to disclose information in a timely and accurate manner can seek compensation, specifically those who bought shares between the company's listing and the close on August 8, 2025 [2] Group 2 - Jihua Group announced the postponement of its 2023 annual shareholders' meeting from June 12, 2024, to June 14, 2024, to ensure a smooth meeting [3] - The postponement complies with relevant laws and regulations, including the rules of the Shanghai Stock Exchange [3] - A shareholder, Xinxing Casting Co., Ltd., submitted a temporary proposal to elect Yin Yue as a non-employee representative supervisor at the annual shareholders' meeting [4] Group 3 - Jihua Group holds 14 patents and 14 copyright registrations according to Tianyancha data [5]
东尼电子股民索赔案已提交立案,红相股份索赔案持续推进
Xin Lang Cai Jing· 2025-09-15 06:30
Group 1 - The core issue involves investor claims against Dongni Electronics (603595) due to false statements leading to legal action initiated by a law firm [1] - The law firm is also pursuing claims for investors of Hongxiang Co., Ltd. (300427), which has faced similar allegations of information disclosure violations [1] - The China Securities Regulatory Commission (CSRC) has opened investigations into both companies for suspected violations of securities laws [1] Group 2 - Hongxiang Co., Ltd. has been found to have false records in its annual reports from 2017 to 2022, with inflated revenues and profits due to fictitious sales and procurement [2] - Specific financial manipulations include an inflated revenue of 104.89 million in 2017, 255.59 million in 2018, and 307.97 million in 2020, among others, significantly impacting reported financials [2] - The company also engaged in fraudulent issuance of shares and bonds, with major false statements in the issuance documents [3][4]
ST天圣财务造假实锤!22人被罚,实控人终身禁入
Shen Zhen Shang Bao· 2025-09-13 12:58
Core Viewpoint - ST Tian Sheng has been penalized by the China Securities Regulatory Commission (CSRC) for inflating profits and failing to disclose related party transactions, resulting in a total fine of 4.99 million yuan [1][4]. Group 1: Financial Misconduct - ST Tian Sheng inflated its total profit by 92,204,254.47 yuan in 2017 and 28,823,001.51 yuan in 2018, which accounted for 30.21% and 20.61% of the reported profits for those years respectively [2]. - The company used off-balance sheet funds to pay sales expenses, leading to inflated profits of 174,783,429.59 yuan in 2017 and 47,908,869.95 yuan in 2018 [2]. - Additionally, ST Tian Sheng understated its profits by 82,579,175.12 yuan in 2017 and 19,085,868.44 yuan in 2018 through inflated procurement costs [2]. Group 2: Disclosure Failures - In 2017 and 2018, ST Tian Sheng failed to disclose related party transactions amounting to 481,025,946.65 yuan and 48,631,061.00 yuan, which represented 15.08% and 1.49% of the net assets at the end of those periods [3]. - The undisclosed related party transactions included 328,521,817.60 yuan that exceeded 15% of the latest audited net assets, violating disclosure regulations [3]. Group 3: Regulatory Actions - The CSRC has issued a warning and imposed a fine of 60,000 yuan for the failure to disclose related party transactions and for the false records in the annual reports [4]. - The former chairman Liu Qun has been fined 90,000 yuan and banned from the market for life due to his role in directing these illegal activities [4]. - Following these actions, ST Tian Sheng's stock will be subject to additional risk warnings, maintaining its designation as "ST Tian Sheng" with a trading code of 002872 [4].
被立案后跌停,白银有色内控失守,半年超400亿营收仍亏超2亿
3 6 Ke· 2025-09-12 11:00
Core Viewpoint - The company Baiyin Nonferrous (601212.SH) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, leading to significant market reactions and a sharp decline in stock price [1][2]. Group 1: Regulatory Investigation - The CSRC has decided to initiate a case against Baiyin Nonferrous due to suspected information disclosure violations, although specific details of the case have not been disclosed [1]. - Following the announcement, Baiyin Nonferrous experienced a one-day stock price drop, closing at 3.82 CNY per share, resulting in a market value loss of approximately 3 billion CNY [1]. Group 2: Internal Control Issues - Baiyin Nonferrous has faced multiple internal control failures, including significant financial misconduct cases that were not disclosed in a timely manner [3]. - Notable incidents include a copper theft case involving 157 million CNY and a zinc ingot theft case where 990 tons were stolen, both of which were not reported in the 2023 annual report [3]. Group 3: Financial Discrepancies - The company reported a financial "black hole" amounting to 388 million CNY due to discrepancies in transactions with three clients, attributed to bribery and improper documentation practices [4]. - Baiyin Nonferrous has initiated legal actions against the involved parties and made provisions for bad debts totaling approximately 31 million CNY and 10 million CNY for two of the clients [4]. Group 4: Financial Performance - In the first half of the year, Baiyin Nonferrous reported a revenue of 44.56 billion CNY but incurred a net loss of 217 million CNY, marking a year-on-year decline of 1859.82% [5][7]. - The company has adjusted its financial statements for previous years, resulting in significant reductions in net profit for 2019, 2020, and 2021 by 41.04%, 65.29%, and 58.28% respectively [7]. Group 5: Production Status - Despite the financial challenges, Baiyin Nonferrous's production remains stable, with an increase in the output of copper, zinc, lead, and other metal products in the smelting system [8].
白银有色遭立案跌停,70年老牌国企内控失守
IPO日报· 2025-09-12 09:03
事件颇具戏剧性,就在立案前一周,公司股价曾连续两日涨停,9月3日公司曾发布公告称,"不存在应披露而未披露的重大信息"。 制图:佘诗婕 一纸立案公告,揭开了一家历史悠久的国有有色金属巨头的内控疮疤。 9月10日盘后,白银有色集团股份有限公司(601212.SH,下称"白银有色")发布公告,称收到证监会《立案告知书》,因涉嫌信息披露 违法违规被正式立案调查。公告发布次日,公司股价开盘即一字跌停,单日市值蒸发约30亿元。 星标 ★ IPO日报 精彩文章第一时间推送 内控失守 2008年,其引入中信集团战略投资完成股份制改造,2017年成为国内A股唯一整体上市的有色冶金国企,注册资本74.05亿元,是国企混 改的典型样本。 具体来看,公司业务覆盖铜、铅、锌、金、银等金属的采、选、冶、加及贸易,已形成国内15座矿山+全球10余国布局的跨国体系。 2023年11月,非公司人员徐某勾结仓库管理员杜某,将990吨锌锭盗出公司仓库,2024年6月法院判决赔偿2267.91万元,但执行仍未到 位。 另外,2024年初,公司原营销中心员工伙同外部人员伪造销售单据,侵占公司价值1.57亿元的阴极铜产品,监察机关已查封冻结涉案资金 5 ...